CClinicalTrials.gg
Not yet recruitingNCT05922189Updated Apr 2, 2024

The Effect of the SBS Decompression Technique on Gastrointestinal Symptoms During the Menstrual Cycle

An interventional study of SBS Decompression Technique and Placebo Technique in Healthy, sponsored by Escola Superior de Tecnologia da Saúde do Porto. Not yet recruiting at 1 site in Portugal. Open to female participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-02.

Sponsored by Escola Superior de Tecnologia da Saúde do Porto · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Female
01

Study summary

Determining the effects of a single application of the sphenobasilar synchondrosis (SBS) decompression technique, on gastrointestinal symptoms during the menstrual cycle is an area that lacks of evidence and proper studies. Therefore the investigators consider this an interesting topic to study.

Read the detailed description

The menstrual cycle is determined by cyclic changes in hormones levels, whose secretion is regulated by the feedback system of the hypothalamic-pituitary-gonadal axis and lasts approximately 28 days. These hormones have direct effects on organs as well as on the peripheral and central nervous systems (CNS), acting alone or in combination to influence both bowel function and gastrointestinal symptoms.

Premenstrually, uterine prostaglandin production can mediate an inflammatory response characterized by pain, and during menstruation, abnormally high levels of prostaglandins in menstrual fluid can induce abnormal uterine contractions. In the intestine, prostaglandins can cause smooth muscle contractions, as well as reduced absorption and induced secretion of electrolytes in the small intestine, increasing gastrointestinal symptomatology.

A study concluded that sphenobasilar synchondrosis (SBS) dysfunctions may be directly related to changes in the endocrine and hormonal system, due to the location of the pituitary gland (endocrine gland responsible for the release mainly of follicle stimulating hormone (FSH) and lutein hormone (LH)). Thus, there is a relationship between the SBS decompression technique and gastrointestinal symptoms during the menstrual cycle.

However this theme lacks of scientific evidence, therefore the investigators intend to collaborate to increase knowledge in this area, determining the effects of the SBS decompression technique, on gastrointestinal symptoms during the menstrual cycle.

02

Conditions studied

  • Healthy

Keywords

  • Gastrointestinal symptoms
  • Menstrual cycle
  • SBS decompression
  • Osteopathy
03

In context

Lead sponsor

Escola Superior de Tecnologia da Saúde do Porto is the lead sponsor of 37 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female;
  • Ages between 18 and 25 years old;
  • Gastrointestinal symptoms in the week before, during, or after menstrual period;
  • Regular menstrual cycle ;
  • Taking an oral hormonal pill.

Exclusion criteria

Exclusion Criteria:

  • People who are undergoing / who have already undergone hormonal therapies;
  • Pregnancy;
  • Orthodontic braces or dental plate;
  • Temporomandibular joint dysfunction or other dysfunction that prevents the opening of the mouth;
  • Present or have presented in the last 3 months any of these conditions: high blood pressure, tumors, acute intracranial bleeding/haemorrhage, increased intracranial pressure, acute skull fracture, convulsive states;
  • Started/changed/stopped taking a hormonal contraceptive method in the last 3 months;
  • BMI greater than 30;
  • Students of osteopathy or being subjected to an osteopathic treatment during the study.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    SBS Decompression Technique

    The technique was preformed until the investigator felt a relaxation of the structures, with a maximum duration of 5 minutes.

    Other: SBS Decompression Technique

  • Placebo comparator
    Placebo Technique

    The technique was preformed during 2 minutes.

    Other: Placebo Technique

Interventions

  • OtherSBS Decompression Technique

    The investigator who applied the technique stood on the right side, laterally to the headboard of the table, with feet flat on the floor, at an appropriate level in relation to the volunteer's headboard, and with a glove on his right hand. Then, he contacted the volunteer's sphenoid wings with his left hand and asked the volunteer to open her mouth, contacting the upper dental arch with the second and third fingers of his right hand. Subsequently, the investigator brought both hands together, followed by an inspiration towards the floor and then a translation towards the ceiling until he felt the structures relax, with a maximum duration of 5 minutes. A second Investigator was sitting on a chair, placed on the opposite side of the head of the table with a stopwatch in his dominant hand, in order to time the application time of each technique.

  • OtherPlacebo Technique

    The investigator was standing, on the right side, laterally to the headboard of the table with feet flat on the floor, at an appropriate level in relation to the headboard of the volunteer's and with a glove on his right hand. Then, he contacted the participant's sphenoid wings with his left hand and asked her to open her mouth. With the second and third fingers of the right hand, he made contact with the upper dental arch. These contacts were maintained for 2 minutes, without moving. A second investigator sat on a chair, placed on the opposite side of the table with the stopwatch in his dominant hand, in order to time the application time of each technique.

06

What researchers measure

Primary outcomes

  1. Change from baseline in abdominal pain pre and post intervention

    The participants were submited to constant evaluation through the diary that they had to fill in daily, during two menstrual cycles, which corresponds to a total of about 2 months. At the end of completing each cycle, the corresponding diary was sent to the researchers, so that they could record the information.

    Time frame: Two months after first intervention

  2. Change from baseline in number of bowel movements (per day) pre and post intervention

    The participants were submited to constant evaluation through the diary that they had to fill in daily, during two menstrual cycles, which corresponds to a total of about 2 months. At the end of completing each cycle, the corresponding diary was sent to the researchers, so that they could record the information.

    Time frame: Two months after first intervention

  3. Change from baseline in type of feces pre and post intervention

    The participants were submited to constant evaluation through the diary that they had to fill in daily, during two menstrual cycles, which corresponds to a total of about 2 months. At the end of completing each cycle, the corresponding diary was sent to the researchers, so that they could record the information.

    Time frame: Two months after first intervention

  4. Change from baseline in nausea pre and post intervention

    The participants were submited to constant evaluation through the diary that they had to fill in daily, during two menstrual cycles, which corresponds to a total of about 2 months. At the end of completing each cycle, the corresponding diary was sent to the researchers, so that they could record the information.

    Time frame: Two months after first intervention

  5. Change from baseline in presence of abdominal distention pre and post intervention

    The participants were submited to constant evaluation through the diary that they had to fill in daily, during two menstrual cycles, which corresponds to a total of about 2 months. At the end of completing each cycle, the corresponding diary was sent to the researchers, so that they could record the information.

    Time frame: Two months after first intervention

  6. Change from baseline in need to take laxatives pre and post intervention

    The participants were submited to constant evaluation through the diary that they had to fill in daily, during two menstrual cycles, which corresponds to a total of about 2 months. At the end of completing each cycle, the corresponding diary was sent to the researchers, so that they could record the information.

    Time frame: Two months after first intervention

07

Study locations

1 site
  • Escola Superior da Saúde do Porto
    Porto, 4200-072, Portugal
08

References and documents

Publications

  • Bharadwaj S, Kulkarni G, Shen B. Menstrual cycle, sex hormones in female inflammatory bowel disease patients with and without surgery. J Dig Dis. 2015 May;16(5):245-55. doi: 10.1111/1751-2980.12247. PubMed 25851437 ↗
  • Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology. 2002 Nov;123(5):1686-701. doi: 10.1053/gast.2002.36603. PubMed 12404243 ↗
  • Dajani EZ, Shahwan TG, Dajani NE. Prostaglandins and brain-gut axis. J Physiol Pharmacol. 2003 Dec;54 Suppl 4:155-64. PubMed 15075457 ↗
  • Lim SM, Nam CM, Kim YN, Lee SA, Kim EH, Hong SP, Kim TI, Kim WH, Cheon JH. The effect of the menstrual cycle on inflammatory bowel disease: a prospective study. Gut Liver. 2013 Jan;7(1):51-7. doi: 10.5009/gnl.2013.7.1.51. Epub 2013 Jan 11. PubMed 23423645 ↗
  • Bernstein MT, Graff LA, Targownik LE, Downing K, Shafer LA, Rawsthorne P, Bernstein CN, Avery L. Gastrointestinal symptoms before and during menses in women with IBD. Aliment Pharmacol Ther. 2012 Jul;36(2):135-44. doi: 10.1111/j.1365-2036.2012.05155.x. Epub 2012 May 24. PubMed 22621660 ↗
  • Parlak E, Dagli U, Alkim C, Disibeyaz S, Tunc B, Ulker A, Sahin B. Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. Turk J Gastroenterol. 2003 Dec;14(4):250-6. PubMed 15048600 ↗
  • Elhadd TA, Neary R, Abdu TA, Kennedy G, Hill A, McLaren M, Akber M, Belch JJ, Clayton RN. Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions. Int Angiol. 2003 Sep;22(3):222-8. PubMed 14612848 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05922189
Lead sponsor
Escola Superior de Tecnologia da Saúde do Porto
Responsible party
Natália Maria Oliveira Campelo (Professor, Escola Superior de Tecnologia da Saúde do Porto) — Principal investigator
First posted
Jun 28, 2023
Start date
Sep 1, 2024 (estimated)
Primary completion
Dec 1, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Apr 2, 2024

Study contacts

Natália MO Campelo, PhD
Contact
ncampelo.estsp.ipp@gmail.com
938674365 ext. +351
Natália MO Campelo, PhD
principal investigator · Escola Superior de Saúde do Politécnico do Porto

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion